Ovarian Cancer Gene Signature May Help Predict Survival, Reveals Novel Therapy Target

Ovarian Cancer Gene Signature May Help Predict Survival, Reveals Novel Therapy Target
A family of genes called homeobox (HOX), involved in the embryo growth process, may be activated in ovarian cancer, resulting in resistance to chemotherapy and poor prognosis, according to researchers at the University of Surrey in England. The study, “The prognostic significance of specific HOX gene expression patterns in ovarian cancer,” published in the International Journal of Cancer,

Knowledge is power when living with ovarian cancer.

Get access to the web’s leading Ovarian Cancer news & insights for as little as 16¢/day.
Subscribe or to access all post and page content.

Leave a Comment

Your email address will not be published. Required fields are marked *